Showing results (41-50 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|April 28, 2016
Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mLAmparo de la Peña, Mary Seger, Danny Soon, et al.
Clinical Pharmacology in Drug Development|May 11, 2016
Investigation of Drug-Drug Interactions Between Ritobegron, a Selective β3 -Adrenoceptor Agonist, With Probenecid in Healthy MenYoshikazu Abe, Yuki Nakano, Toru Kanazawa, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
The pharmacodynamics, pharmacokinetics, safety and tolerability of inhaled fluticasone furoate and vilanterol administered alone or simultaneously as fluticasone furoate/vilanterolRodger Kempsford, Ann Allen, Philippe Bareille, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Effect of CYP2C19 polymorphism on the pharmacokinetics of rosuvastatin in healthy Taiwanese subjectsRichard D Finkelman, Tzung-Dau Wang, Yi Wang, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A comparative pharmacokinetic and pharmacodynamic study of FSK0808 versus reference filgrastim after repeated subcutaneous administration in healthy Japanese menKyoko Matsuguma, Shunji Matsuki, Kei Sakamoto, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitorMonette M Cotreau, Nicholas M Siebers, James Miller, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Lack of tyramine pressor response effect with oral CX157: A specific reversible MAOIDaniel Burch, Mahnaz Asgharnejad, William Gerson, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
A randomized, double-blind, multiple-dose, placebo-controlled, dose escalation study with a 3-cohort parallel group design to investigate the tolerability and pharmacokinetics of albaconazole in healthy subjectsAlbert J Dietz, Joanna C Barnard, Koen van Rossem
Clinical Pharmacology in Drug Development|April 30, 2016
Caspofungin exposure-response relationships in adult patients with mucosal or invasive candidiasisWendy Comisar, Peng Sun, Susan Li, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteersEmma Boström, Kristina Claeson Bohnstedt, Karl-Gustav Jostell, et al.
Pageof 135